Switch to:
GuruFocus articles
Headlines from internet
Nov-16-17$12.79 (+1.51%)
06:48PMCan Learn Tevas Q3 Report Seekingalpha
01:15PMIt’s Not a Buy? Why Valeant’s Stock Could Have 25% Upside Barron's
Nov-15-17$12.6 (+7.23%)
04:30PMWhy The Children's Place, Teva Pharmaceutical Industries, and Sears Holdings Jumped Today Fool
03:14PMWill Teva’s Pipeline Lead It to the Promised Land? Barron's
01:23PMGeneral Nutrition Anatomy Short Win Seekingalpha
08:47AMAstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA Zacks
07:00AMWall Street Breakfast Order War Dubai Airshow Seekingalpha
03:52AMSeth Klarmans Baupost Group Margin Safety Portfolio Seekingalpha
Nov-14-17$11.75 (+0.09%)
12:43PMThis ETF's Best Move Was Avoiding Israel's Worst-Performing Stock Bloomberg
10:18AMAntares Pharma Sale Seekingalpha
08:29AMOrexigen (OREX) Q3 Loss Narrower Than Expected, Stock Up Zacks
Nov-13-17$11.74 (-0.34%)
03:32PMDaily Pharma Scoop Regenerons Appeal Good News Amgen Bristol Myers Sprycel Seekingalpha
03:07PMValeant: Is the Rally Over? Barron's
10:29AMSenators Question Allergan Market Monopoly Seekingalpha
08:04AMTeva's stock drops after J.P. Morgan downgrades to rare bearish rating MarketWatch
10:43AMValeant Surges Post Q3 Reassessment Seekingalpha
Nov-10-17$11.78 (-0.59%)
05:01PMWhy tax-bill fears may be one big contributing factor in junk bond slump MarketWatch
03:30PMMomenta Pharmaceuticals, Inc.'s Rough Month Fool
01:45PMSum Fears Small Pharma Seekingalpha
10:08AMValeant Pharma: Why This Bear Still Growls Barron's
09:58AMBioDelivery (BDSI) Q3 Earnings, Sales Beat Estimates Zacks
Nov-09-17$11.85 (+0.17%)
03:48PMIt’s Getting Better All the Time…Even for Valeant Barron's
11:21AMBiotech Forum Daily Digest Redhills Bungled Secondary Seekingalpha
10:15AMThe Russell 2000 is diverging from the S&P 500 — should you worry? MarketWatch
09:44AMBuy Neurocrine Cheaper Prices Seekingalpha
08:09AMVIVUS (VVUS) Q3 Loss Narrows, Qsymia Falters, Shares Down Zacks
03:26AMDaily Pharma Scoop Portola Upside Novartis Reports Positive Cosentyx Data Keryx Tumbles Seekingalpha
Nov-08-17$11.83 (+1.2%)
03:02PMValeant: Up 6.8%, But Still Not a Buy? Barron's
12:28PMTeva Stop Tucking Away Seekingalpha
Nov-07-17$11.69 (-5.8%)
11:26AMTTeva’s stock and bonds walloped after Fitch downgrade to junk MarketWatch
09:44AMTeva Stock Could Plunge Another 50% After Debt Cut to Junk theStreet
09:00AMAllergan Keeps Heading Lower. Is It Time to Buy? Fool
08:44AMMorning Movers: The Road Less Travelled Barron's
08:36AMTeva Pharmaceuticals' Ratings Cut at Fitch to 'BBB-' theStreet
07:38AMTeva's stock, bonds fall after credit rating slashed to junk at Fitch MarketWatch
04:11AMTeva Seekingalpha
Nov-06-17$12.41 (+8.86%)
03:57PMTeva’s Credit Rating Cut to Junk by Fitch Bloomberg
03:16PMForget Mylan N.V.'s Dismal Third-Quarter Results -- Its Future Is Looking Better Fool
12:52PMTeva Pharmaceutical Industries Limited 2017 Q3 Results Earnings Call Slides Seekingalpha
11:04AMMylan (MYL) Misses on Earnings and Sales Estimates in Q3 Zacks
07:32AMPharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication for Kymriah Zacks
04:07AMTeva New Ceo Starts Work Seekingalpha
10:46AMWeek Review Xynomic Signs 502 Million Deal Boehringers Raf Inhibitor Seekingalpha
01:42AMWeek Review November 3 2017 Seekingalpha
Nov-03-17$11.4 (+1.51%)
03:54PMTeva Value Trap Seekingalpha
01:18PMSay It Ain’t So: Teva Dividend Must Go? Barron's
12:30PMTeva Punished Weak Outlook Seekingalpha
12:24PMValeant Uceris Patent Loss Impair Salix Seekingalpha
11:02AMTeva (TEVA) Stock Plunges 20% on Q3 Earnings Miss & View Cut Zacks
Nov-02-17$11.23 (-19.9%)
08:46PMThe Single Biggest Reason Teva Pharmaceutical Industries Imploded and Fell 22% in October Fool
06:54PMNeurocrines Ingrezza Launch Continues Exceed Expectations Seekingalpha
05:09PMTevas Q3 Crash Bear Reviews Updates Story Seekingalpha
02:06PMWhy Teva Pharmaceutical Is Crashing Today Fool
01:59PMMomenta's (MNTA) Biosimilar Study Fails, Q3 Loss Narrows Zacks
01:36PMOuch! Teva Needs An IV, Stat Barron's
01:28PMTevas Troubles Just Beginning Seekingalpha
01:26PMGeneric drugmakers, distributor shares slide after Teva reports worse pricing environment MarketWatch
01:10PMHere's Why Neurocrine Biosciences Is Soaring Fool
10:56AMTeva’s latest quarter was even worse than already-low expectations MarketWatch
10:41AMTeva Stock Plunges on Earnings Results, but It's Still Not a Buy theStreet
10:07AMOuch! Teva Needs An IV, Stat Barron's
09:44AMTeva plunges 18% after drugmaker lowers 2017 outlook again cnbc
09:43AMDaily Pharma Scoop Teva Q3 Results Boost Redhill Clovis Reports Rubraca Sales Seekingalpha
08:13AMFutures point to a weak open ahead of Apple earnings, Fed Chair decision cnbc
07:36AMTeva (TEVA) Q3 Earnings Miss, Cuts 2017 View, Stock Falls Zacks
07:26AMTeva Pharmaceutical Plunges After Slashing Its 2017 Forecast Bloomberg
07:21AMTeva shares drop 8% on Q3 profit, revenue misses; lowered 2017 outlook MarketWatch
04:41AMWorld's Largest Generic Drug Maker Seeks Tie Up With Producer of Chinese Viagra Bloomberg
Nov-01-17$14.02 (+1.59%)
05:44PMWill Weak Guidance Sink Teva Seekingalpha
03:42PMHow Allergan plc Lost $4 Billion in Q3 and Still Performed Quite Well Fool
10:48AMAllergan (AGN) Tops Q3 Earnings Estimates, Tweaks 2017 View Zacks
08:29AMMomenta shares plunge 14% on Q3 profit, revenue misses MarketWatch
Oct-31-17$13.8 (+1.85%)
01:52PMStates Target Mylan President, Emcure Exec in Generic Drug Lawsuit theStreet
01:19PMTeva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt MarketWatch
12:20PMUS states to expand generic drug price-fixing suit: Report cnbc
12:15PMDear General Electric Investors Please Learn Teva Pharmaceuticals Complications Seekingalpha
09:50AMBiotech Forum Daily Digest Possible Buyout Scenarios Neos Therapeutics Seekingalpha
06:13AM3 Retiree Stocks You'll Want to Buy Now Fool
Oct-30-17$13.55 (+1.73%)
10:31AMIs a Turnaround in Store for Teva (TEVA) in Q3 Earnings? Zacks
08:07AMPerrigo Base Plus Plus Strategy Plus Seekingalpha
Oct-27-17$13.32 (-2.7%)
12:53AMMylan Teva Generic Delzicol Sting Allergan Seekingalpha
Oct-26-17$13.69 (-1.72%)
09:00AMMorgan Stanley Just Found 37 Challenged Stocks That Still Have No Hope theStreet
07:37AM3 Value Stocks for Smart Investors Fool
07:35AMMylan shares rise 1.7% premarket on UK patent win MarketWatch
Oct-25-17$13.93 (-2.45%)
10:45AMAnother Dividend Cut Teva Seekingalpha
Oct-24-17$14.28 (-1.79%)
01:51PMTeva Earnings Forecast Seekingalpha
08:17AMIs Regeneron Pharmaceuticals, Inc. Stock a Buy? Fool
07:33AM3 Small, Profitable Biotechs With Fantastic Growth Fool
Oct-23-17$14.54 (-2.42%)
12:32PMDaily Pharma Scoop Adamis Upside Potential J And Js Simponi Label Expansion Sgens Adcetris Seekingalpha
07:03AM3 Things You Should Expect in Gilead Sciences' Q3 Results Fool
05:43AMAllergan Linzess Restasis 2_0 Seekingalpha
01:00AMTuesday Was Blacker Than Monday; Tax Reform's Role -- Jim Cramer's Top Thoughts theStreet
08:02AMCan Teva Pharmaceutical's Dividend Even Survive? Fool
Oct-19-17$14.93 (+2.12%)
08:20AMTeva Submits BLA to FDA for Migraine Candidate Fremanezumab Zacks
08:19AMZacks Market Edge Highlights: Gilead, Biogen, Teva, AbbVie and Aetna Zacks
08:00AMZacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi Zacks
07:51AM3 Value Stocks for Retirees Fool
12:18AMJ And J Unattractive Seekingalpha
Oct-18-17$14.62 (-0.81%)
04:30PMWhy SUPERVALU, Synchronoss Technologies, and Allergan Slumped Today Fool
03:59PMPricing Pressure, Competition Remain Headwinds for Pharma Stocks Zacks
02:01PMTeva Bulls Early Debt Downgrade Way Seekingalpha
12:28PMShares of large generic drugmakers fall MarketWatch
03:36AMAllergan Pharma Darling Faces Uncertainty Seekingalpha
Oct-17-17$14.74 (+0.2%)
06:33PMWhere to Find Value in Healthcare Stocks Zacks
04:44PMAllergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall Zacks
03:59PMAnd For Allergen’s Next Trick..Filling a $1.5 Billion Hole? Barron's
03:52PMTeva Long Bull Case Seekingalpha
03:45PMAdamis Pharmaceuticals Buy Dip Ahead Symjepi Partnership Launch Seekingalpha
10:00AM3 Dividend Healthcare Stocks Fool
08:44AMZacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen Zacks
Oct-16-17$14.71 (-1.8%)
04:05PMTevas Ongoing Complications Psychology Generic Drugs Seekingalpha
02:59PMPharma Industry Outlook - October 2017 Zacks
02:23PMJudge invalidates Allergan patents on dry-eye medicine Restasis cnbc
11:21AMSanofi Upward Trajectory 2017 Seekingalpha
08:51AMTeva Market Underreacted Copaxone News Stock Just Cheap Seekingalpha
10:45AMDividend Income Update September 2017 Seekingalpha
Oct-13-17$14.98 (-1.12%)
04:17PMImprove Returns Lower Risk Exposure Seekingalpha
01:38PMTeva Rushes Match 30 Percent Discounts Generic Copaxone Seekingalpha
12:21PMLost beneath headlines of five-figure drug costs — pharmaceutical price growth is weakening MarketWatch
01:15AMA New FDA Approval Sends Small Cap Flexion Soaring Fool
12:35AMWhy Do Companies Pay Dividends? Fool
Oct-12-17$15.15 (-3.87%)
09:57AMBiotech Forum Daily Digest Revisiting Rocket Known Cymabay Therapeutics Seekingalpha
Oct-11-17$15.76 (-0.82%)
10:50AMAllergan Bulls Brace Generic Restasis Seekingalpha
08:58AMCapital Allocation: Buybacks, Dividends, and More Fool
08:30AMMylan Gets Complete Response Letter For Biosimilar Neulasta Zacks
07:20AMMylan Deals a Blow to Teva Pharmaceutical Fool
12:00AMThe Pharma Chief Who Sees Profit Where Skeptics See Lousy Odds Bloomberg
Oct-10-17$15.89 (+0.76%)
06:02AM$50,000 Per Year in Prescription Drugs? You Likely Know Someone Who Used at Least That Much Fool
Oct-09-17$15.77 (-1.07%)
09:32AMValeant’s Biggest Drug Gets a Shot at More Sales Barron's
12:50AMAntares Pharma Will October Deliver Triple Play Seekingalpha
01:05PMUnited Therapeutics Seems Time Sell Stock 2017 Seekingalpha
10:34AM3 Drug Stocks That Soared This Week: Are They Buys? Fool
07:07AMMedical Drug Stocks Best Wealth Builders Now Seekingalpha
Oct-06-17$15.94 (+1.66%)
03:10PMSenator Seeks Thwart Allergans Patent Transfer Seekingalpha
11:00AMIs Allergan plc a Bargain After a $7.6 Billion Dip in September? Fool
Oct-05-17$15.68 (-2.49%)
05:52PMInterview Shire Controversial Dry Eye Market Seekingalpha
11:02AMTeva Fdas Bombshell Seekingalpha
06:49AMMylan Generic Copaxone Punish Teva Seekingalpha
05:47AMChanges And T Forward Looking Cramers Lightning Round 10 4 17 Seekingalpha
04:27AMTeva Might Getting Sicker Stock Drops Seekingalpha
Oct-04-17$16.08 (-14.56%)
04:25PMTeva Copaxone Competition Comes Worst Time Seekingalpha
03:52PMThe Hot Stock: My Oh Mylan! Barron's
03:40PMMylan Way 60 Seekingalpha
12:04PMTeva Receives Big Blow Generics Pricing Seekingalpha
09:37AMMylan’s surprise generic win sends Teva, Momenta shares plunging MarketWatch
08:55AMTeva: Yes, There’s a Bright Side Barron's
05:32AMMylan jumps 15% premarket after FDA OK for MS drug MarketWatch
05:32AMMylan jumps 15% premarket after FDA OK for MS drug MarketWatch
Oct-02-17$18.47 (+4.94%)
10:22AMAntares Numerous Upcoming Catalysts Seekingalpha
04:06AMTeva Kicks Can Road Seekingalpha
Sep-29-17$17.6 (+2.56%)
09:52AMTeva Taken Second Step First Seekingalpha
Sep-27-17$17.62 (+2.09%)
06:18AM41 State Attorneys General Lock Horns Opioid Manufacturers Seekingalpha
Sep-26-17$17.26 (+0.52%)
08:43AMImf September Buys 17 Stocks Added Fund Seekingalpha
Sep-20-17$17.11 (-0.47%)
11:31AMDaily Pharma Scoop Gerons Growth Potential Ipsens Xarmelo Approval Gsks Ellipta Approved Seekingalpha
Sep-19-17$17.19 (+1.18%)
11:20PMTeva Sales Mind Proceeds Seekingalpha
10:03AMMylan Time Sell Seekingalpha
Sep-18-17$16.99 (-6.13%)
01:07PMTeva 1_1 Billion Asset Sale Much Ado Nothing Seekingalpha
12:25PMTeva Pharmaceutical Opportunity Falling Knife Part 2 Seekingalpha
10:06AMMylan Attacks Allergans Desperate Measures Protect Restasis Seekingalpha
Sep-14-17$18.36 (-2.65%)
05:28PMTeva Looks Hit Insys Hurts Seekingalpha
04:43PMTeva Pharmaceuticals Finally Positive News Seekingalpha
02:24PMTevas New Ceo Blessing Seekingalpha
01:23PMBiotech Forum Daily Digest Revisiting Radius Health Seekingalpha
08:39AMAldeyra Spikes Significant Improvements Midstage Dry Eye Study Seekingalpha
Sep-13-17$18.86 (-2.43%)
12:22PMTeva Avoid Seekingalpha
05:55AMBuy Low Sell High Cramers Mad Money 9 12 17 Seekingalpha
Sep-12-17$19.33 (+4.49%)
05:59PMTeva Caution Warranted Seekingalpha
12:35PMBiotech Forum Daily Digest Spotlighting Sophiris Bio Seekingalpha
07:00AMWall Street Breakfast Apples Biggest Event Years Seekingalpha
03:02AMIndivior Fall Generic Suboxone Arrives Seekingalpha
Sep-11-17$18.5 (+19.35%)
04:26PMTeva Worth Considering Buoyant Market Seekingalpha
01:06PMTeva Pharmaceutical: Talk About a Good Hire! Barron's
07:06AMTeva Turning Point Seekingalpha
04:15AMAllergan Enjoins St Regis Mohawk Tribe Protect Restasis Patents Seekingalpha
01:55PMTop Dividend Raises Cuts August 2017 Seekingalpha
07:15AMEagle Pharmaceuticals: Strong Upside Potential Despite Recent Heatstroke Stumble Seekingalpha
Sep-01-17$15.9 (+0.25%)
11:46AMAllergan: Restasis Is Under Siege By Mylan And Teva Seekingalpha
Aug-31-17$15.86 (+2.59%)
09:06AMAbbVie: Making It Less Risky Seekingalpha
Aug-30-17$15.46 (-1.97%)
02:17PMTeva: A Complete Overview Seekingalpha
Aug-28-17$15.93 (-1.73%)
06:51AMMartin Shkreli: This Week In Investing (19) Seekingalpha
Aug-23-17$16.49 (-3.06%)
10:51AMCoty: Anatomy Of A Short Seekingalpha
Aug-22-17$17.01 (-0.18%)
04:51PMTeva: The Perfect Storm Has Created The Perfect Opportunity Seekingalpha
03:40PMAbbvie May Become The New Teva Seekingalpha
Aug-21-17$17.04 (-1.5%)
10:14PMPfizer: Investors Are Missing The True Impact Of Xtandi Seekingalpha
12:33PMThe Troubles Never End For Teva Seekingalpha
Aug-18-17$17.3 (+1.17%)
03:39PMTeva Pharmaceutical Industries Limited 2017 Q2 - Results - Earnings Call Slides Seekingalpha
01:53PMSnippet Roundup: Transparency For Straumann But A Black Box For Pfizer Seekingalpha
10:13AMTGIF - Market Ends Week On A Rough Note Seekingalpha
Aug-17-17$17.1 (-2.23%)
03:24PMANI Pharmaceuticals Valued Cheaply Ahead Of Re-Commercialization Of Corticotropin Products Seekingalpha
Aug-16-17$17.49 (-2.67%)
06:45AMDon't Buy Teva Pharmaceutical - Cramer's Lightning Round (8/15/17) Seekingalpha
Aug-15-17$17.97 (+4.72%)
12:13PMTeva: On The Activist Radar Seekingalpha
Aug-14-17$17.16 (-0.81%)
05:08PMThe Fish Market: What Is Amarin Worth? Seekingalpha

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat